RPTOR and hepatocellular carcinoma: The present study is the first to our knowledge to demonstrate that phosphorylation of mTOR Ser2481 was specifically inhibited in HCC cell lines harboring activated mTORC1/Raptor when treated with nanomolar concentrations of mTORC1 inhibitors.